본문 바로가기
KERD
논문KCI 등재

편두통 예방에서 토피라메이트와 연관된 인지기능장애

Topiramate Related Cognitive Dysfunction during Migraine Prevention

박성파|정두교
대한신경과학회 (Korean Neurological Association)|2005.02|대한신경과학회지 (Journal of the Korean Neurological Association)|제23권 제1호|pp. 55-61

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류신경과학

초록

Abstract

Background: Topiramate (TPM), a broad-spectrum antiepileptic drug, has recently been demonstrated to be effective as a monotherapeutic device for migraine prevention. We investigated the impact of TPM on cognition during migraine prevention. Methods: Twenty-eight migraineurs were evaluated. They were instructed to take 25 mg of TPM per day, with 25 mg weekly increments to a maximum of 100 mg per day according to the therapeutic responsiveness. We assessed cognitive dysfunctions by spontaneous patient reports and several neuropsychological tests comparing the baseline and at 3 months during on-treatment. We also compared these tests to age, sex, education, clinical features of migraine, TPM dose, and global effectiveness. Results: After 3 months of therapy, 21 patients undertook a follow-up neuropsychological test. Even though headache frequency, severity, and disability were significantly decreased in a follow-up period, there was a significant impairment in backward digit span (P=.006) and verbal fluency (P=.023). Thirteen patients (62%) showed an impaired backward digit span, and 11 patients (52%) exhibited an impaired verbal fluency. Five patients (24%) complained of symptoms associated with these impairments. Cognitive impairments were well correlated to the frequency of migraine attack, higher daily TPM dose, and global effectiveness. In six patients who showed the impairment of both items, TPM was withdrawn and their cognition was retested after 2 weeks. There was a significant improvement in these cognitive functions. Conclusions: TPM appears to exert a dose-related, strong negative influence on working memory and verbal fluency during migraine prevention. It can be related to drug tolerability.

참고문헌 (24)

  1. "Prevalence of migraine in Korean adults:A nationwide survey", 1, pp.57~66 (2000)
  2. "Migraine patients experience poorer subjective well-being", quality of life even between attacks, 1995, pp.15, 31~36
  3. "Medical consultation for migraine:results from the American Migraine Study", 38, pp.87~96 (1998)
  4. "Burden of migraine in the United States:disability and economic costs", 159, pp.813~818 (1999)
  5. "Duke University Center for Clinical Health Policy Research Drug Treatments for the Prevention of Migraine Headache Department of Commerce" (1999)
  6. "Topiramate in the preventive treatment of episodic migraine:a combined analysis from pilot,double-blind,placebo-controlled trials", 8, pp.428~432 (2003)
  7. "Topiramate in migraine prevention", 61, pp.490~495 (2004)
  8. "Topiramate for migraine prevention:a randomized controlled trial", 291, pp.965~973 (2004)
  9. "Postmarketing experience with topiramate and cognition", 42, pp.1134~1140 (2001)
  10. "Topiramate in clinical practice:long-term experience in patients with refractory epilepsy referred to tertiary epilepsy center", 5, pp.380~387 (2004)
  11. "A multicenter,randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures", 41, pp.1167~1178 (2000)
  12. "Effects of topiramate on cognitive function", 69, pp.636~641 (2000)
  13. "Differential cognitive and behavioral effects of topiramate and valproate", 60, pp.1483~1488 (2003)
  14. "Topiramate and word-finding difficulties in patients with epilepsy", 60, pp.1104~1107 (2003)
  15. "The effects of adjunctive topiramate on cognitive function in patients with epilepsy", 44, pp.339~347 (2003)
  16. "Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients", 54, pp.171~178 (2003)
  17. "Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders", pp.7 1~96
  18. "Clinical utility of an instrument assessing migraine disability", pp.854~861
  19. "Cognitive and behavioural assessment in clinical trials", pp.155~157
  20. "Cognitive and behavioural assessment in clinical trials", pp.159~161
  21. "Auditory naming and temporal lobe epilepsy", 35, pp.229~243 (1999)
  22. "Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients:their relationship with the clinical manifestations of the illness", 22, pp.291~302 (2002)
  23. "Acquired transient stuttering during a migraine attack", 40, pp.170~172 (2000)
  24. "Migraine and cognitive function:a life-course study", 59, pp.904~908 (2002)

관련 논문AI추천

경두개 자기자극을 이용한 편두통 환자의 시각피질 흥분성에 대한 divalproex sodium의 효과강병욱, 김은희, 김정일, 박성파, 서정규, 이호원, 정두교대한신경과학회 · 대한신경과학회지2004 · 제22권 제5호Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients황희, 김기중, 김우중, 김훈민, 유일한, 임병찬, 채종희, 최지은대한신경과학회 · Journal of Clinical Neurology2017 · 제13권 제3호만성 편두통에서의 보톡스 치료류상효대한신경과학회 · 대한신경과학회지2024 · 제42권 제1호만성 두통 환자에서 Botulinum Toxin Type A 치료김시현, 김은성, 문동언, 문영은대한통증학회 · The Korean Journal of Pain2005 · 제18권 제1호혈관성 두통환자에서의 Transcranial Doppler이용이혜승, 정진상대한임상신경생리학회 · Annals of Clinical Neurophysiology1999 · 제1권 제1호삽화군발두통에서 240 mg 갈카네주맙의 예방 효과모희정, 송민준, 조수진대한신경과학회 · 대한신경과학회지2021 · 제39권 제3호

이 간행물의 다른 논문 (13건)

뇌졸중 후 발생하는 감정장애: 우울, 불안, 감정조절장애, 분노조절장애, 그리고 피로김종성pp. 1-8허혈성 뇌졸중 환자에서 대사증후군과 호모시스테인의 관계신동진, 박종호, 이영배, 신원철, 박현미pp. 9-14지역사회 거주 노인에서 한국판 Instrumental Activities of Daily Living (K-IA이)에 영향을 미치는 인자들이승한, 정슬기pp. 15-20알쯔하이머병 환자의 인지기능 변화 및 예후인자: 1년 추적홍태용, 윤성민, 인연권, 이은아, 성상민, 곽강호, 김상윤, 김태유pp. 21-27원발성 정상압수두증 환자에서 보행장애와 중뇌 크기의 상관관계허균, 안영환, 용석우, 이필휴pp. 35-40
원문 보기